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T follicular helper (Tfh) cells are the subset of CD4T helper cells that are required for genera-
tion and maintenance of germinal center reactions and the generation of long-lived humoral
immunity.This specializedT helper subset provides help to cognate B cells via their expres-
sion of CD40 ligand, IL-21, IL-4, and other molecules. Tfh cells are characterized by their
expression of the chemokine receptor CXCR5, expression of the transcriptional repres-
sor Bcl6, and their capacity to migrate to the follicle and promote germinal center B cell
responses. Until recently, it remained unclear whetherTfh cells differentiated into memory
cells and whether they maintain Tfh commitment at the memory phase. This review will
highlight several recent studies that support the idea of Tfh-committed CD4 T cells at the
memory stage of the immune response. The implication of these findings is that memory
Tfh cells retain their capacity to recall theirTfh-specific effector functions upon reactivation
to provide help for B cell responses and play an important role in prime and boost vaccina-
tion or during recall responses to infection. The markers that are useful for distinguishing
Tfh effector and memory cells, as well as the limitations of using these markers will be dis-
cussed. Tfh effector and memory generation, lineage maintenance, and plasticity relative
to otherT helper lineages (Th1,Th2,Th17, etc.) will also be discussed. Ongoing discoveries
regarding the maintenance and lineage stability versus plasticity of memory Tfh cells will
improve strategies that utilize CD4 T cell memory to modulate antibody responses during
prime and boost vaccination.
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INTRODUCTION
Effective B cell responses to infectious diseases or immuniza-
tion require the assistance of CD4+ helper T cells. A specialized
subset of CD4 T cells named T follicular helper (Tfh) cells are
required for providing this help to antigen-specific B cells. With-
out cognate Tfh help, activated B cells are unable to generate and
maintain the germinal center response that is required for efficient
somatic hypermutation of immunoglobulin genes and the selec-
tive processes that facilitate affinity maturation of antibodies (1,
2). Furthermore, the germinal center reaction is the origin of long-
lived memory B cells and long-lived plasma cells that populate the
periphery and bone marrow (respectively), and provide long-term
antibody-mediated protection against (re)exposure to pathogens
(3). Thus, Tfh cells play a critical role in the generation of effective
and long-lived humoral immune responses to antigens (1).
T follicular helper cells were first identified as a subset of CD4
T cells isolated from human tonsils (4, 5). These cells expressed
the B cell follicle homing chemokine receptor CXCR5 and the
inducible costimulator (ICOS), and localized within the germi-
nal center (4, 5). Furthermore, these human tonsil CXCR5+ cells
(compared to CXCR5−CD45RO+ T cells) efficiently promoted
production of class switched immunoglobulin (Ig)G and IgA in T
cell:B cell co-culture assays (4–6). Interestingly, CXCR5+ CD4 T
cells from human blood, which were presumed to be the memory
counterparts of CXCR5+ cells in tonsils and lymph nodes, did
not efficiently produce the Th1 signature cytokine IFNγ or the
Th2 cytokines IL-4, IL-5, and IL-13 (5). Together, these studies
suggested that the CXCR5+ Tfh cells represented a novel subset of
helper T cells with the specific functions of providing help for B cell
responses and that are distinct from Th1 and Th2 cells. Since these
initial seminal reports describing Tfh cells, extensive studies have
demonstrated that while Tfh cells share certain similarities with
Th1, Th2, and Th17 cells (depending upon context of infection or
vaccination), these cells have unique developmental requirements
and distinct phenotypic, homing, and functional qualities com-
pared to other T helper cell lineages (Th1, Th2, Th17, Treg) (1).
Upon activation with cognate antigen by dendritic cells,
antigen-specific CD4 T cells can differentiate to become vari-
ous types of effector CD4 T cells with specific roles in promoting
anti-pathogen immune responses (Figure 1). Early differentiation
toward the Tfh lineage requires ICOS expression and signaling
to induce expression of the transcriptional repressor Bcl-6 (7).
Bcl6 is required for Tfh cell generation, maintenance, and func-
tion, establishing Bcl6 as a central regulator in Tfh cell lineage
development (Figure 1) (8–10). Bcl6 expression promotes Tfh
differentiation, at least in part by suppressing transcription of
the transcriptional regulators Tbet, RORγt, GATA3, and Blimp-
1 (8–10), and through other potential mechanisms, such as the
repression of microRNAs (10). In addition, cytokines such as IL-6
and IL-21 (11), and other molecules such as SAP are important for
Tfh differentiation and function (12,13). Importantly, interactions
with cognate B cells were required for amplifying the expression of
Bcl6 for the maintenance of the Tfh phenotype during the immune
response (7). During Tfh differentiation, Bcl6 plays an important
role in suppressing Blimp1 (8), which is a regulator of Th1, Th17,
and Th2 lineage cells (1). Thus, the promotion of Bcl6 coupled to
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FIGURE 1 |T follicular helper cell differentiation and context-dependent
Tfh cell heterogeneity. Following activation of naïve CD4 T cells, cells
proliferate and undergo fate decisions in response to cytokines and other
differentiating factors. Tfh cell differentiation is influenced by IL-6 and IL-21,
and dependent upon ICOS signaling for expression of the transcription
factor Bcl6. Cytokines including IL-12, IL-4, IL-1β, and many others, direct
(A)Th1, (B)Th2, and (C)Th17 cell differentiation, respectively. The
context-dependent cytokine milieu also influences Tfh cell differentiation;
thus, Tfh effector cells can express some low/intermediate levels of the
transcription factors Tbet, Gata3, and RORγt, which are associated with the
(A)Th1, (B)Th2, and (C)Th17 cell lineages, respectively.
the repression of Blimp1 plays a role in the differentiation, func-
tion, and possibly the stability of Tfh cells in relation to other T
helper cell subsets. Additional transcription factors such as Maf
(14, 15), Ascl2 (16), and others play important roles in Tfh cell
differentiation and/or function (1).
T follicular helper cells have developmental requirements that
differ from those that promote Th1, Th2, and Th17 effector cell
development (1). However, depending upon the type of infection
(viral, helminth, fungal, etc.) or immunization and the inflamma-
tory environment that is generated, Tfh cells can express low to
intermediate levels of Tbet, Gata3, or RORγt (Figure 1) (17–20).
This intriguing context-dependent transcription factor expres-
sion in Tfh cells results in a variety of Tfh cell subsets that can
express low levels of specific cytokines that can influence anti-
body class switching (17, 21, 22). Thus, studying the complex
relationship between Tfh cells and their non-Tfh cell counterparts,
and whether they remain phenotypically and functionally distinct
throughout the immune response and beyond is critical to under-
standing Tfh cell commitment and flexibility and to determining
their biologically important roles during specific types of immune
responses.
LINEAGE-COMMITTED MEMORY T HELPER CELLS
The adaptive immune system responds to infectious challenge with
two major goals. The first goal is to generate sufficient numbers
of antigen-specific effector cells to limit and clear the pathogen.
The second priority is to provide long-lasting immunity that
will defend the host from subsequent exposure to the pathogen
(23). The activation-driven proliferation and lineage differenti-
ation of CD4 T cells in vivo is accompanied by the progression
of memory differentiation. Following clearance of antigen, the
majority (approximately 90–95%) of antigen-specific effector T
cells undergo apoptosis, leaving behind a population of memory
cells. In some experimental models, antigen-specific CD4 mem-
ory T cells gradually decline over long periods of time (24, 25).
For example, Listeria monocytogenes infection-induced memory
CD4 T cells are present at relatively high frequencies 90 days post-
infection; however, by approximately 250 days post-infection, the
population has largely disappeared from the spleen and lymph
nodes (25). In contrast, human studies reveal that long-lived
vaccinia-specific memory CD4 T cells are relatively stable for at
least several decades after smallpox vaccination (26, 27).
Memory T cells possess many important features compared to
their naïve CD4 T cell precursors. First, antigen-specific mem-
ory cells are found in increased numbers relative to their naïve
antigen-specific precursors, providing better coverage and a more
rapid cellular response upon pathogen rechallenge. Second, mem-
ory cells are not restricted to blood circulation and secondary
lymphoid organs, but instead may also traffic to and reside in
non-lymphoid tissues, where they may rapidly exert effector func-
tions if their specified pathogen gains entry to that particular
anatomical site. Third, memory T cells have undergone changes
in cell-intrinsic programing, allowing them to rapidly recall their
effector functions, such as prompt expression of specific effector
cytokines, chemokines, and cytotoxic molecules. Finally, mem-
ory cells are long-lived, and a central feature of their longevity is
dependent on their ability to undergo homeostatic proliferation
in the absence of antigen (23, 28).
Combining the study of T helper lineage differentiation and T
cell memory differentiation in vivo following vaccination or infec-
tion is incredibly complex. However, it provides the opportunity to
gain vital understanding into the heterogeneity and lineage com-
mitment and flexibility of the resulting antigen-specific memory
CD4 T cells that will be informative for ongoing and future vaccine
discovery/development efforts. It has become clear that among the
vast heterogeneity of memory CD4 T cells, many memory cells
demonstrate commitment to a previously defined T helper lin-
eage. The existence of Th1-commited long-lived memory CD4 T
cells was demonstrated in BAC transgenic mice that used a reporter
to indicate transcription of the Ifng gene. In this study, Harrington
et al. demonstrated that these memory cells were derived from the
effector Th1 cells, and rapidly recalled IFNγ expression at the effec-
tor phase (29). Several other studies similarly found that subsets of
LCMV-specific and Listeria-specific memory CD4 T cells with dis-
tinct phenotypes were committed Th1 memory cells that recalled
IFNγ expression and expression of other Th1 effector molecules
(20, 30, 31). One study utilized an IL4 IRES EGFP reporter mouse
to demonstrate that Th2 effector cells (EGFP+) generated from N.
brasiliensis infection could provide anti-parasite protective immu-
nity after adoptive transfer into immunocompromised recipient
mice and 30 days resting before parasite challenge (32). Similarly,
Trichuris-specific Th2 memory cells recall their Th2 effector func-
tions and mediate anti-parasite immunity (33). While Th17 CD4
T cells generated by intranasal Listeria infection (a Th1 pathogen)
do not form memory cells (25), Candida and other fungal vaccines,
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as well as other conditions have been shown to induce Th17 mem-
ory cells in vivo (34–36). Together, these studies demonstrate the
characteristics and programs of polarized effector Th1, Th2, and
Th17 cells that are generated early during effector differentiation
are preserved in resting memory cells. Importantly, these effector
programs are recalled after reactivation in vivo to infectious chal-
lenge in an antigen-specific manner, and with the appropriate T
helper effector response to effectively eliminate the pathogen.
T FOLLICULAR HELPER MEMORY CELLS
The establishment of Tfh cells as an independent effector T helper
subset, and the factors that drive Tfh differentiation being defined,
provides a strong rationale for exploring whether Tfh cells that
progress to become memory cells maintain their Tfh attributes
following resolution to the immune response. However, given the
potential flexibility/plasticity of Tfh cells toward repolarization
(37), one might predict that Tfh cells generate non-committed
memory CD4 T cells. Several fundamental questions exist regard-
ing the relationship of Tfh cells and memory cells. First, do Tfh
cells survive to become memory cells? Second, do memory cells
derived from Tfh cells maintain their commitment/programing to
recall Tfh effector cells, or, instead possess pluripotency/plasticity
to become cells of other T helper lineages? The answer to these
questions provides profound insight into the importance of how
Tfh differentiation during primary immune responses to natural
infection and vaccination have the potential to influence secondary
antibody responses. Several recent studies have provided insight
into the existence and characteristics of memory Tfh cells and
their capacity to recall Tfh-specific effector functions following
reactivation with antigen.
One early study investigating memory Tfh cells in mice
described a population of CXCR5+ICOS+ cells in the drain-
ing lymph nodes 30–56 days following immunization with pigeon
cytochrome C in adjuvant. Compared to day 7 Tfh effector cells,
day 30 PCC-specific cells had decreased ICOS and OX40 expres-
sion. The authors reported that these were a subset of memory Tfh
cells with enhanced recall capacity upon immunization 6–8 weeks
after priming (38). However, this study further reported the per-
sistence of antigen for more than 75 days after immunization and
the maintenance of CD69 on these PCC-specific CD4 Tfh cells
indicate that this experimental system promotes long-lived anti-
gen depots. Thus, the CXCR5+ICOSlo cells identified in this study
cannot be clearly distinguished as true memory cells that survive
in the absence of antigen (38).
A study by MacLeod and Marrack provided a stronger basis for
the existence of memory CD4 T cells with accelerated Tfh function
during recall responses (39). Their study demonstrated that on a
per cell basis, antigen-specific memory CD4 T cells (compared to
Ag-specific naïve cells) provided accelerated B cell responses and
antibody class switching. Interestingly, this accelerated B cell helper
capacity was contained within the CXCR5+ subset of memory
CD4 T cells, resulting in higher OVA-specific IgG1 titers following
adoptive cell transfer and followed by immunization. The authors
suggested that CXCR5 chemokine receptor expression promotes
their more rapid migration of reactivated memory CD4 T cells to
B cell follicles, allowing them to provide accelerated help to the B
cell response (39).
It was unknown whether Tfh cells were able to survive and
become memory cells. To address this question, Weber et al. used
protein immunization in CFA to induce TCR transgenic CD4
effector T cells, sorted them into CXCR5− and CXCR5+ sub-
sets, and then adoptively transferred these into naïve recipient
mice (40). Fourteen days later, adoptively transferred CXCR5+
effector cells had become CXCR5 low/negative. After resting these
cells in naïve recipient mice for several weeks, a large proportion
of transferred Tfh cells quickly recalled a Tfh phenotype within
2.5 days following re-immunization, expressing higher levels of
PD-1, Bcl6, CXCR5, and IL-21 compared to non-Tfh cells and pri-
mary effector cells (40). While the time periods that these cells were
rested in the absence of antigen were relatively brief, this study was
highly suggestive that effector Tfh cells could be maintained in the
absence of antigen and preferentially recall a Tfh phenotype. A
study by Choi and colleagues addressing the fate commitment of
Tfh cells demonstrated that day 3 LCMV-specific Tfh effector cells,
following adoptive transfer into day 3 LCMV-infected (infection-
matched) recipient mice, were maintained up to 45 days later
and retained CXCR5 surface expression (41). An additional study
demonstrated that CXCR5+RFP+ (from Bcl6 RFP reporter mice)
OTII cells induced by Ova/CFA immunization can persist follow-
ing adoptive transfer for 20 days, and upon OVA+CFA immuniza-
tion preferentially recall Tfh cells in the draining lymph node (42).
Together, these studies clearly demonstrate that not all Tfh effector
cells are terminally differentiated and fated to die. Instead, some
Tfh effector cells progress to become memory cells that have some
similar features compared to their Tfh effector predecessors.
Our study investigated the differentiation of Th1 and Tfh
cells following acute LCMV infection using the adoptive trans-
fer and analysis of LCMV-specific CD4 T cells (SMARTA TCR
transgenic) induced by acute viral infection (20). Following the
clearance of acute LCMV infection and the corresponding con-
traction of virus-specific CD4 T cells, both Th1 and Tfh memory
subsets are maintained at relatively stable numbers for approx-
imately 60–150 days post-infection (20). Resting PD-1− and
ICOS−CXCR5+Ly6clo memory CD4 T cells shared phenotypic
and gene expression similarities to CXCR5+Ly6clo effector Tfh
cells, suggesting a direct lineage-relationship between these pop-
ulations at the different stages of the immune response. Adoptive
transfer of CXCR5+ memory subsets followed by LCMV Arm-
strong challenge resulted in Tfh secondary effector cells with ability
to rapidly recall a Tfh effector phenotype and promote the gen-
eration of germinal center B cells. In addition, when CXCR5+
memory cells were transferred to B cell deficient recipient mice
that were then infected, a large proportion of the resulting effector
cells recalled and sustained a Tfh-like phenotype, while primary
effector cells generated from naïve (uncommitted) SMARTA cells
did not. These latter results indicate that CXCR5+ memory cells
have acquired and maintained a Tfh-biased cell program rela-
tive to their naïve cell counterparts (20). Interestingly, while there
was some apparent flexibility by some CXCR5+ memory cells to
generate CXCR5− Th1-like secondary effector cells, cell-intrinsic
restrictions impaired the Th1 effector program, resulting in poor
granzyme B and IFNγ expression. The results from this study
argue in favor of Tfh lineage commitment within the CXCR5+
Tfh memory cell population (20).
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In contrast to these many studies that report the existence of
memory Tfh cells that promptly and preferentially recall Tfh phe-
notype and function upon rechallenge, one study reported that
L. monocytogenes specific (identified by MHC class II tetramer)
CXCR5+ memory CD4 T cells are pluripotent, promoting the
recall of both Tfh cells and non-Tfh (Th1) cells (31). Another study
of influenza infection in IL-21 GFP reporter mice showed that the
adoptive transfer of polyclonal CXCR5+GFP+ Tfh CD4 effector
cells gave rise to memory cells with sufficient plasticity to gener-
ate secondary effectors of both Tfh cells and non-Tfh cells. Thus,
Luthje et al. conclude that Tfh effector cells are “uncommitted”
regarding their T helper lineage (43). Interestingly, these stud-
ies both used adoptive transfer of polyclonal CD4 T cells (31, 43),
while studies demonstrating relative Tfh commitment of CXCR5+
Tfh memory cells utilized TCR transgenic cells specific for a single
epitope (20, 40, 42). Because strength and/or longevity of TCR sig-
naling influences Th1 versus Tfh differentiation (44, 45) as well as
memory CD4 T cell differentiation (46), individual TCRs within
the Tfh effector population may confer varying degrees of lineage
commitment in CXCR5+Tfh memory cells. Going forward, it will
be interesting to determine whether different TCRs, infection and
immunization systems, and other factors play a role in the degree
of plasticity versus commitment in memory Tfh cells.
There are many well described Tfh cell markers; however, there
are relatively few markers useful for clearly distinguishing rest-
ing memory Tfh cells. Antigen-specific memory Tfh cells express
CXCR5, but lack Bcl6, ICOS, and expression of many other Tfh
molecules (20, 41, 47) (Figure 2). In addition, memory Tfh cells
do not express CD69 (20), an indicator of ongoing antigen stim-
ulation. A recent study demonstrated that folate receptor 4 (FR4),
a surface receptor that is upregulated on Tfh cells but not Th1
cells during acute viral infection, is maintained on the surface of
CXCR5+ memory Tfh cells (48). To date, the best marker for
identifying memory Tfh cells is CXCR5 (18, 20, 41, 47) (Figure 2);
however, not all CXCR5+memory cell subsets exhibit specific Tfh
function upon reactivation (47). Figure 2 shows some of the phe-
notypic markers associated with the memory Tfh cell phenotype.
It has become clear that Tfh effector cells can become memory
Tfh cells with cell-intrinsic programs that promote the recall of Tfh
cells upon reactivation. It is therefore possible to propose models of
T helper cell differentiation wherein naïve CD4 T cells give rise to
Tfh and other T effector lineage cells (Th1,Th2,or Th17 depending
upon context of the pathogen or inflammation), and these effector
cells give rise to memory cells that strictly maintain their lineage
commitment and recall their lineage upon reinfection or boosting
with antigen (Figure 3A). However, memory T cell populations
are characterized by a vast degree of phenotypic and functional
heterogeneity. A second and more comprehensive model would
suggest that as effector cells differentiate, individual cells acquire
varying degrees of programing toward the Tfh or other T effector
lineage cells that can be stably maintained in resting memory cells
(likely through epigenetic mechanisms) (Figure 3B). The resulting
population of antigen-specific memory cells would then contain
a wide spectrum of cells with varying degrees of lineage commit-
ment versus pluripotency/plasticity (Figure 3B). This latter model
may account for why some studies report lineage commitment
within Tfh cell subsets, while others studies report relative non-
commitment or plasticity. Future mechanistic studies will provide
improved insight into the heterogeneity of memory CD4 T cells in
relation to their T helper lineage commitment and recall potential.
Furthermore, determining whether Tfh memory cells are home-
ostatically maintained over time at very late memory timepoints
remains to be explored.
HUMAN T FOLLICULAR HELPER MEMORY CELLS
The original reports describing CXCR5+ Tfh cells in human
tonsils had differing ideas regarding the existence of memory
Tfh cells. One report described that tetanus-antigen-specific pro-
liferation was induced in CD4+CD45RO+CXCR5− but not
CD4+CD45RO+CXCR5+ cells, thus suggesting that Tfh cells
likely disappear along with germinal centers, and are prone to
apoptosis due to their high levels of Fas expression (4). In con-
trast, the other report showed that unlike the activated tonsillar
CXCR5+ CD4 T cells that were CD69+HLA-DR+ICOS+, cir-
culating CXCR5+ cells in human blood are CD69−HLA-DR−
ICOS−, and hypothesized that these blood CXCR5+ cells repre-
sent memory Tfh cells (5). Since these initial observations, whether
activated human Tfh cells become memory T cells, and whether
FIGURE 2 | Markers of effector and memoryTfh cells. Tfh effector CD4 T
cells express high levels of the chemokine receptor CXCR5, the inhibitory
receptor PD-1, ICOS, the transcriptional repressor Bcl6, the transcription
factor c-Maf, and many other molecules. After antigen clearance, resting
memory Tfh cells no longer express Bcl6, ICOS, and IL-21 and many other Tfh
associated molecules. Tfh memory cells are characterized by intermediate
expression of CXCR5 and other Tfh related molecules and the absence of
activation dependent molecules. Bcl6 expression is not detected in memory
Tfh cells; however, Maf and other transcription factors are maintained at
low/intermediate levels. PD-1 is absent from antigen-specific memory Tfh
cells in mice, however, human CXCR5+CXCR3− memory Tfh cells maintain
low levels of PD-1 expression that is not dependent on TCR signaling. Folate
receptor 4 (FR4), a molecule that is highly expressed on effector Tfh cells, is
maintained on CXCR5+ memory Tfh cells.
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FIGURE 3 | Models ofT helper lineage commitment in memory CD4T
cells. Following activation, naïve CD4 T cells undergo dramatic antigen
dependent proliferation to generate effector CD4 T cells. Following antigen
clearance, the majority of effector cells undergo apoptosis, leaving behind a
pool of antigen-specific memory cells. Upon reinfection or antigen boost,
memory cells become reactivated and proliferate, generating secondary
effector cells. (A) Potential model for lineage commitment of Tfh memory
cells. In this model, antigen-specific CD4 T cells differentiate to become
either lineage-committed Tfh cells or lineage-committed effector cells of
other lineages (either Th1, Th2, or Th17 depending upon the context of
infection or inflammatory stimulus). Resting memory Tfh and non-Tfh cells
would maintain their lineage-specific programing, and upon reactivation,
would faithfully recall their previously defined T helper lineage phenotype
and functions. (B) In this second model, antigen-specific CD4 T cells
differentiate toward either Tfh or non-Tfh (Th1, Th2, or Th17) effector cells;
however, depending upon the integration of many different stimuli (TCR
signals, inflammation, interactions with various antigen-presenting cells,
etc.), individual effector cells become transcriptional and epigenetically
programed with varying degrees of polarity toward Tfh or non-Tfh cell
lineages. Following antigen clearance and T cell contraction, the
antigen-specific memory pool is highly heterogenous, being comprised of
cells with varying degrees of lineage commitment and T helper
lineage-specific recall potential, including highly committed Tfh memory
cells, more plastic/pluripotent Tfh and non-Tfh (Th1, Th2, and Th17) memory
cells, and highly committed non-Tfh (Th1, Th2, and Th17) memory cells.
they maintain their Tfh function upon reactivation has remained
unclear. Recent reports have shed light on the nature of human
CXCR5+memory Tfh cell ontogeny and function (18, 37, 47).
One study described a population of circulating human
CXCR5+ central memory CD4 T cells that expressed CXCL13
and promoted B cells to undergo plasma cell differentiation and
Ig secretion (37). Another recent study investigating circulating
CXCR5+ CD4 T cells in human blood revealed that these cells
share functional characteristics with Tfh cells. CXCR5+ cells pro-
moted the isotype switching and antibody production of IgG, IgA,
and IgE isotype switched antibodies in T:B cell co-culture exper-
iments, while CXCR5− cells did not promote switched antibody
production (18). Their study further categorized the CXCR5+
population into CXCR3+CCR6− (Th1-like), CXCR3−CCR6+
(TH17-like), and CXCR3−CCR6− (Th2-like) subsets. While
CXCR5+CXCR3+CCR6− cells did not provide help in these
co-culture assays, CXCR5+CXCR3−CCR6+ cells promoted high
levels of IgG and IgA antibodies, while CXCR5+CXCR3−CCR6−
cells promoted high IgG and IgE, and intermediate levels of IgA.
This study highlights the function of reactivated CXCR5+ CD4 T
cells from peripheral blood to promote antibody production, and
further defines the vast heterogeneity of CXCR5+ cells in rela-
tion to the Th1, Th2, and Th17 lineage of cells (18). The CD69−
and ICOS− phenotype of these circulating CXCR5+ cells (prior
to reactivation) suggests that they are resting memory cells (18).
However, inability to identify antigen-specific cells and relate them
to a known time of antigen exposure lead to difficulty in conclud-
ing whether they are indeed true memory Tfh cells that persist
long-term in the absence of antigen and maintain their lineage
characteristics in their resting state.
Locci et al. profoundly advanced the understanding of human
Tfh memory cells and clarified their existence. Their study
identified that blood CXCR5+CXCR3− cells that had a non-
activated/resting phenotype could be stratified into either PD-1−
or PD-1low subsets (47). Interestingly, low PD-1 expression was
stably maintained on this latter subset of cells during 20 day cul-
ture in vitro in the absence of TCR stimulation, suggesting that
sorted CXCR5+PD-1low cells express these molecules (PD-1 and
CXCR5) as a part of the Tfh transcriptional program. Indeed, the
transcriptional profile of these CXCR5+CXCR3−PD-1low cells
is similar (albeit reduced) to that of germinal center Tfh cells
from human tonsils, and these cells promoted the highest IgG
antibody production and plasmablast differentiation in T:B cell
co-culture experiments compared to other subsets of CXCR5+
cells (47). Furthermore, characterization of tetanus-specific CD4
T cells in healthy human donors (identified using HLA tetramers
bearing tetanus peptide), demonstrated the existence of this
CXCR5+CXCR3−PD-1low phenotype among resting antigen-
specific memory cells (Figure 2). Together, these experiments
define the phenotype and function of human memory Tfh cells
and combine to fortify the idea that memory Tfh cells exist within
the pool of resting human antigen-specific memory cells (47).
Defining strategies and markers to distinguish and character-
ize antigen-specific human Tfh effector and memory subsets is
difficult, and is the focus of many recent and current lines of
research (18, 47, 49–51). The vast heterogeneity of effector and
memory CD4 T cells in human blood and other tissues has led
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to difficulty in understanding what Tfh-like cell subsets serve
as the best correlates of effective antibody responses, and what
subsets actually provide the help for the B cell response in vivo
(51). Some of the differences for Tfh and/or Tfh memory mark-
ers utilized in these various studies may result from the different
types of infections or vaccinations studied, the timepoints ana-
lyzed (early after vaccination versus long-lived memory cells), and
the varying analysis of “bulk” memory populations of unknown
antigen-specificities versus analysis of tetramer+ pathogen spe-
cific memory cells (18, 47, 49–51). As better markers, reagents,
and methods for studying antigen-specific Tfh responses become
available, the developmental requirements and heterogeneity of
human memory Tfh cells and their relationship to other T helper
cell subsets will be better understood. This will open doors to more
clearly define the specific roles that Tfh memory cells play during
recall responses by human Tfh cells during boosting or in response
to natural infection.
PRESERVING THE Tfh PROGRAM IN RESTING MEMORY Tfh
CELLS
A complex combination of cytokines, transcription factors (52),
STAT molecules (53), and epigenetic changes (54, 55) combine
to delineate both the initial differentiation and stability of T
helper lineages. Extrinsic factors that drive CD4 T cell acti-
vation and T helper cell differentiation are absent after anti-
gen/pathogen clearance. Consequently, transcription factors such
as Tbet and Bcl6 and other molecules that define T helper lin-
eages are downregulated on memory CD4 T cells (20, 31, 40,
41). A critical question regarding the existence of CXCR5+ Tfh
memory cells (and other specialized T helper cell memory sub-
sets) remains: how do memory cells maintain lineage commitment
and remember the gene expression programs of their previously
defined T helper lineage in the absence of antigen and inflamma-
tory signals (Figure 4A) (56, 57)? While the answer to this question
for memory Tfh cells is currently not resolved, it is likely that the
FIGURE 4 | Potential mechanisms that promoteTfh recall responses
from memoryTfh cells. (A) Differentiated CXCR5+ memory Tfh cells
possess cell-intrinsic programs that promote the preferential generation of
Tfh secondary effectors cells upon reactivation with antigen. In contrast,
uncommitted naïve CD4 T cells are pluripotent, with the capacity to
generate a balance of Tfh and non-Tfh (Th1, Th2, Th17) effector cells
following activation. (B)The maintenance of Tfh associated transcription
factors may promote the recall of the Tfh cell program and inhibit the
differentiation of other T helper lineages following activation. The
transcription factor Maf, is maintained at low levels in human Tfh memory
cells. While Bcl6 expression is not detectable in memory Tfh cells, it is
possible that soon after reactivation, rapid reexpression of Bcl6 directs Tfh
gene expression as well as inhibits Blimp1 and high expression of Tbet,
Gata3, and RORγt. (C) CXCR5 and CCR7 coexpression on memory Tfh
cells may provide localization of memory Tfh cells along the T:B cell border
either before or early after reactivation, promoting increased interactions
with B cells that can reinforce the Tfh cell phenotype and function. In
contrast, CCR7+ (CXCR5−) naïve CD4 T cells will become activated in T
cells zones by antigen-bearing dendritic cells. (D) Epigenetic programs
acquired during Tfh effector differentiation can be maintained in resting
memory Tfh cells throughout homeostatic proliferation. Transcriptionally
permissive histone modifications and unmethylated DNA at “poised” Tfh
associated loci in memory Tfh cells will promote the rapid reexpression of
these genes upon reactivation. In addition, repressive histone
modifications and DNA methylation will prevent reexpression of Th1, Th2,
and Th17-associated genes.
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reexpression of key transcription factors, as well as the epigenetic
state of genes related to Tfh cell development and function, play
an important role in directing Tfh memory cells toward recall-
ing a secondary Tfh response. Potential mechanisms (that are not
mutually exclusive – and more likely work in concert) for preserv-
ing the program of Tfh memory cells that promote the recall of
Tfh secondary effector cells are shown in Figures 4B–D.
Bcl6 plays a critical role in defining the phenotype and function
of Tfh cells (8–10). Although all of the mechanisms by which this
transcriptional repressor positively directs the Tfh gene expression
program, Bcl6 expression can induce CXCR5 expression (9, 15),
likely through an indirect mechanism. Bcl6 overexpression in naïve
human CD4 T cells promotes the regulation of genes required for
germinal center trafficking and interactions with B cells, and in
cooperation with Maf induces expression of other key Tfh genes
(15). It is clear that while many Tfh associated genes are down-
regulated in resting CXCR5+ memory cells, these cells maintain
a Tfh-like gene expression profile for many other Tfh associated
genes (20, 47). Bcl6 transcript was not detectable in memory Tfh
cells (20, 41, 42, 47). However, this does not rule out that very
low levels of Bcl6 expression could bias the recall of memory
Tfh cells early after cell reactivation by promoting the Tfh phe-
notype and inhibiting Blimp1 activity (Figure 4B). Furthermore,
because memory B cells can present antigen to and rapidly induce
Bcl6 expression in memory Tfh cells (58), the Bcl6-dependent Tfh
transcriptional program may be robustly reinforced in memory
Tfh cells upon reactivation in vivo.
Maf gene and protein expression were found at low lev-
els in human blood Tfh memory cells (CXCR5+CXCR3−
PD-1+) (47), suggesting that this important transcriptional reg-
ulator of Tfh cell functions (14, 15) may play a role in preserving
aspects of the Tfh phenotype and program in these memory cells.
In addition, Ascl2, a recently described transcription factor was
shown to be required for early Tfh differentiation and function
(16). Overexpression of Ascl2 results in CXCR5 expression, CCR7
downregulation, and subsequent migration to the follicles. Ascl2
binds to conserved non-coding sequence regions of the Cxcr5
locus and promotes Cxcr5 gene expression. Interestingly, Ascl2
did not induce Bcl6 expression. It is therefore possible that Ascl2
expression in Tfh memory cells may be important for maintenance
of CXCR5 expression in resting memory Tfh cells (16). Currently,
it is unclear what specific roles Bcl6, Maf, Ascl2, or other transcrip-
tion factors play in preserving CXCR5 expression on memory Tfh
cells, and promoting maintenance of the Tfh gene expression pro-
gram (Figure 4B). Upon reactivation, it is possible that CXCR5+
Tfh memory cells are already localized (or rapidly relocalize) to
the T:B border, resulting in interactions with B cells that would
then reinforce Bcl6 reexpression and other Tfh transcription fac-
tors (Figure 4C). In turn, this might preferentially promote the
Tfh program (over other T helper lineage programs) during the
secondary response (Figure 4C). Currently, it remains unclear how
these and other transcription factors influence the maintenance of
the Tfh program and the repression of other T helper cell lineages
in Tfh memory cells.
Transcription factors that have been termed lineage “master
regulators,” such as Tbet, RORγt, and Gata3 are not always limited
in their expression to a single subset of differentiated CD4 T cells
and can be expressed in Tfh effector cells (Figure 1) (1). The
expression of these factors in Tfh effector cells is believed to be
important for promoting expression of key cytokines that direct
specific isotype class switching in cognate germinal center B cells
(17, 21, 22). The balance of Bcl6 and Tbet has been shown to
have important effects of differentiation and gene expression by
Th1 and Tfh cells (59–61). Interestingly, following LCMV infec-
tion, mouse Tfh cells co-express Bcl6 and intermediate levels of
Tbet (20). The resulting Tfh memory cells do not have detectable
Bcl6, but surprisingly, maintain low levels of Tbet gene and pro-
tein expression (20). Despite this Tbet expression (and lack of
Bcl6), adoptively transferred Tfh memory cells predominantly
generate Tfh secondary effector cells following reinfection (20).
This finding invokes the idea that beyond the simple balance
of lineage-associated transcription factors, transcriptional pro-
graming through epigenetic modifications likely plays a role in
promoting the reexpression of Tfh genes and repressing the gene
expression programs of other T helper cell lineages (57).
The maintenance of gene expression and lineage-differentiation
programs in the absence of inflammatory/differentiating signals is
reinforced by epigenetic programs that are acquired during the
initial effector T cell differentiation (54, 57). The combination
of epigenetic modifications to histones to regulate the structure
of chromatin and the methylation of DNA at CpG motifs that
determine the binding of inhibitory methyl-binding domain pro-
teins can be conserved in daughter cells throughout cell division
(62), providing a mechanism for gene expression programs to be
maintained during T cell homeostatic proliferation (57). Further-
more, transcriptionally permissive epigenetic marks are positively
associated at loci of lineage-specific cytokines for each T helper
lineage, while repressive marks at specific loci relevant to other
T helper lineages serve to prevent inappropriate gene expression
and suppress the differentiation toward alternative lineages (54,
57). Lu et al. observed that positive chromatin marks were associ-
ated in Tfh-like cells at the Tbx21, Gata3, and Rorc loci, and that
these cells could be repolarized toward Th1, Th2, and Th17 cells
when restimulated under polarizing conditions (63). This study
highlights that certain features of the Tfh program may partially
overlap with Th1, Th2, and Th17 cell programs, possibly allowing
greater plasticity toward the capacity to produce multiple lineage-
defining cytokines. In addition, in vitro differentiated Th1 and
Th2 cells (but not Th17 cells) can become Tfh cells following
adoptive transfer and immunization with protein in adjuvant (42).
Together, these studies demonstrate that there is a degree of flex-
ibility between effector Tfh cells and other T helper cells. Further
work is required to determine whether and how such flexibility
applies to CXCR5+memory Tfh cells generated in vivo. It is pos-
sible that context-dependent selective processes during memory
T cell development promote antigen-specific memory T cells that
are either more or less committed to Tfh differentiation compared
to their effector (precursor) counterparts (Figure 3).
Methylation of CpG motifs in regulatory regions of genomic
DNA serve as a transcriptionally repressive mark through recruit-
ment of methyl-binding domain proteins (62, 64). Loss of DNA
methyltransferase activity has dramatic effects upon CD4 differ-
entiation, resulting in loss of restriction of key lineage-associated
cytokine and transcription factor genes (65–69). DNA bisulfite
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sequencing analysis of LCMV-induced CD4 T cells revealed that
the Gzmb locus (encoding granzyme B) became demethylated in
Th1 but not Tfh effector cells. Furthermore, the maintenance
of DNA methylation at the Gzmb locus in CXCR5+ memory
Tfh cells was predictive of both their capacity to recall the Tfh
effector phenotype upon reactivation with antigen in vivo, and
also their inability to efficiently express granzyme B, even among
the small fraction of Th1-like secondary effector cells that had
downregulated CXCR5 expression (20). Thus, repression of Th1-
associated gene expression programs (such as Gzmb) in mem-
ory Tfh cells likely plays an important role in the maintenance
of the Tfh program in resting CXCR5+ Tfh memory cells by
repressing the expression of genes associated with Th1 effec-
tor function (Figure 4D). Future work is needed to characterize
permissive versus repressive epigenetic marks (for loci of lineage-
associated cytokines, effector molecules, and transcription factors)
in antigen-specific memory Tfh, Th1, Th2, and Th17 cells, provid-
ing needed insight into the plasticity versus commitment of mem-
ory CD4 T cell subsets induced by infection and immunization.
CONCLUDING REMARKS
The discovery that phenotypically unique subsets of CXCR5+
memory CD4 T cells have recall potential specific for Tfh func-
tion invites important questions for future study that will inform
vaccination strategies for infectious diseases. Understanding the
mechanisms of how Tfh memory cells acquire and preserve the
Tfh gene expression programs and preferentially recall these pro-
grams upon reactivation will provide important insight into the
lineage maintenance and plasticity of these cells. Finally, future
work is needed to determine the optimal ways to utilize Tfh mem-
ory cells during prime and boost immunization to promote ways
that improve protective and long-lived antibody responses.
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